Market Insights Health Hospitals Inpatient Care

Treatment of Musculoskeletal Diseases - G7

The Treatment of Musculoskeletal Diseases market in the G7 countries is projected to reach a staggering revenue of US$99.73bn by 2024.
It is expected to show a moderate annual growth rate (CAGR 2024-2029) of 2.09%, which will result in a market volume of US$110.60bn by 2029.
When compared globally, United States is anticipated to generate the highest revenue in this market, with an estimated amount of US$60,790.00m in 2024.
In the United States, the rising trend in the treatment of musculoskeletal diseases is the increased adoption of minimally invasive surgical techniques.

Key regions: Europe, Canada, United States, Germany, India

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.